Correlation Between Citigroup and Odonate Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Citigroup and Odonate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Odonate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Odonate Therapeutics, you can compare the effects of market volatilities on Citigroup and Odonate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Odonate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Odonate Therapeutics.

Diversification Opportunities for Citigroup and Odonate Therapeutics

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Citigroup and Odonate is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Odonate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Odonate Therapeutics and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Odonate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Odonate Therapeutics has no effect on the direction of Citigroup i.e., Citigroup and Odonate Therapeutics go up and down completely randomly.

Pair Corralation between Citigroup and Odonate Therapeutics

Taking into account the 90-day investment horizon Citigroup is expected to generate 1.39 times less return on investment than Odonate Therapeutics. But when comparing it to its historical volatility, Citigroup is 1.68 times less risky than Odonate Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Odonate Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  175.00  in Odonate Therapeutics on August 31, 2024 and sell it today you would earn a total of  5.00  from holding Odonate Therapeutics or generate 2.86% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy4.81%
ValuesDaily Returns

Citigroup  vs.  Odonate Therapeutics

 Performance 
       Timeline  
Citigroup 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Citigroup are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Citigroup exhibited solid returns over the last few months and may actually be approaching a breakup point.
Odonate Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Odonate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Odonate Therapeutics is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Citigroup and Odonate Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Citigroup and Odonate Therapeutics

The main advantage of trading using opposite Citigroup and Odonate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Odonate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Odonate Therapeutics will offset losses from the drop in Odonate Therapeutics' long position.
The idea behind Citigroup and Odonate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios